国海证券研报指出，2025年 巨化股份归母净利润同比大幅提升，看好制冷剂景气持续。公司为制冷剂 全球龙头企业，是国内拥有第一至四代含氟制冷剂系列产品，同时拥有新型含氟冷媒（氢氟醚D系列、 全氟聚醚JHT系列）、碳氢制冷剂产品（3.5万吨/年）以及系列混配制冷剂的生产企业。公司制冷剂生 产配额优势明显，据2026年度氢氟碳化物生产、进口配额核发表，国家核定公司（含控股子公司） HCFC-22生产配额3.84万吨，占全国26.30%，其中内用配额占全国31.55%，为国内第一；HFCs生产配 额29.99万吨，占全国同类品种合计份额的37.58%。同时，公司第四代含氟制冷剂（HFOs）品种及有效 产能国内领先（现运营两套主流HFOs生产装置，产能约8000吨/年；计划通过新建+技术改造新增产能 近5万吨）。公司是全球氟制冷剂龙头企业，制冷剂生产配额领先，随着制冷剂价格上涨，公司有望充 分受益，快速发展。维持"买入"评级。 ...

国海证券研报指出，2025年巨化股份归母净利润同比大幅提升，看好制冷剂景气持续。公司为制冷剂全 球龙头企业，是国内拥有第一至四代含氟制冷剂系列产品，同时拥有新型含氟冷媒（氢氟醚D系列、全 氟聚醚JHT系列）、碳氢制冷剂产品（3.5万吨/年）以及系列混配制冷剂的生产企业。公司制冷剂生产 配额优势明显，据2026年度氢氟碳化物生产、进口配额核发表，国家核定公司（含控股子公司）HCFC- 22生产配额3.84万吨，占全国26.30%，其中内用配额占全国31.55%，为国内第一；HFCs生产配额29.99 万吨，占全国同类品种合计份额的37.58%。同时，公司第四代含氟制冷剂（HFOs）品种及有效产能国 内领先（现运营两套主流HFOs生产装置，产能约8000吨/年；计划通过新建+技术改造新增产能近5万 吨）。公司是全球氟制冷剂龙头企业，制冷剂生产配额领先，随着制冷剂价格上涨，公司有望充分受 益，快速发展。维持"买入"评级。 ...

Group 1 - The core viewpoint is that the air conditioning market is expected to maintain stable growth by 2026, with the supply and demand of the mainstream third-generation refrigerant R32 remaining in a tight balance [1] - The demand for R134a is anticipated to increase due to the rapid development of new energy vehicles, leading to a tighter supply-demand balance [1] - The supply-demand relationship for R125 is also expected to be tight due to a small internal quota ratio and reduced social inventory [1] Group 2 - The refrigerant industry faces challenges with some companies having incomplete quota varieties and limited quota numbers, which may lead to adjustments in the production of high GWP refrigerants when prices rise [1] - Guosen Securities predicts that the mainstream third-generation refrigerants will maintain a tight supply-demand balance, with a long-term trend of tightening refrigerant quota constraints [1] - The development of the liquid cooling industry is viewed positively, as it is expected to increase the demand for fluorinated liquids and refrigerants [1] Group 3 - Jinshi Resources, a leading upstream fluorite resource company, announced plans to invest 257 million yuan to acquire a 15.7147% stake in Zhejiang Noah Fluorochemical Co., becoming its second-largest shareholder [2] - This transaction is seen as a strategic extension into the high value-added fine fluorochemical sector by Jinshi Resources [2] - Noah Fluorochemical specializes in the R&D, manufacturing, and sales of fluorinated electronic chemicals, with a current production capacity of 5,000 tons of fluorinated liquids [2]

Investment Rating - The investment rating for the company is "Buy" [9] Core Insights - The company reported a revenue of 3.79 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 12.0%. The net profit attributable to shareholders reached 470 million yuan, a significant year-on-year increase of 220.4%. The net profit excluding non-recurring items was 460 million yuan, up 223.7% year-on-year. In Q3 alone, the company achieved a revenue of 1.34 billion yuan, a year-on-year increase of 11.4% and a quarter-on-quarter increase of 2.5%. The net profit for Q3 was 200 million yuan, reflecting a year-on-year increase of 485.8% and a quarter-on-quarter increase of 13.7% [2][6][12]. Summary by Sections Financial Performance - For the first three quarters of 2025, the company achieved a total revenue of 3.79 billion yuan, with a net profit of 470 million yuan and a net profit excluding non-recurring items of 460 million yuan. In Q3, the revenue was 1.34 billion yuan, with a net profit of 200 million yuan [2][6]. Market Trends - The refrigerant market continues to show positive trends, with the company’s fluorocarbon chemicals generating a revenue of 730 million yuan in Q3, a year-on-year increase of 5.9%. The average price for various refrigerants showed mixed trends, with some prices increasing significantly [12][13]. Profitability Metrics - The company’s gross margin for Q3 was 27.4%, an increase of 12.6 percentage points year-on-year, while the net margin was 14.8%, up 12.0 percentage points year-on-year. The increase in profitability is attributed to the ongoing positive trends in the refrigerant market [12][13]. Future Outlook - Looking ahead to Q4, the company anticipates continued growth in the third-generation refrigerants, while the second-generation refrigerants may face short-term pressure. The company has several projects under construction, including 80,000 tons of hydrofluoric acid and over 30,000 tons of fluoropolymer materials, which will support sustainable business development [12][13].

Investment Rating - The investment rating for the company is "Buy" [5][12] Core Views - The company reported a significant increase in revenue and net profit for the first half of 2025, with revenue reaching 13.33 billion and net profit at 2.05 billion, representing year-on-year growth of 10.36% and 145.84% respectively [2][4] - The refrigerant business continues to drive the company's performance, with the average price of fluorinated refrigerants recovering, contributing significantly to profit growth [3][4] - The company has ongoing projects that are expected to enhance future performance, including the construction of high-performance fluorinated materials projects [3] Summary by Sections Financial Performance - In 25H1, the company achieved a gross margin of 28.72% and a net margin of 17.07%, reflecting improvements of 11.99 and 9.43 percentage points year-on-year [2] - Revenue from various business segments showed diverse growth, with refrigerants up by 55.09% year-on-year [2][3] Business Segments - The company’s revenue from fluorinated chemical raw materials, refrigerants, and fluorinated fine chemicals showed significant increases, with refrigerants alone contributing 6.09 billion in revenue [2][3] Future Outlook - The company expects net profits to grow to 4.41 billion, 5.31 billion, and 6.53 billion for the years 2025, 2026, and 2027 respectively, with corresponding PE ratios of 22.16, 18.39, and 14.96 [4][11]